Nerra Network

Archives
Log in
Subscribe
August 20, 2026

Moderna's personalized mRNA vaccine cut melanoma… · DP Pod 🌱

View this email in your browser
The DP Pod: The Do Positive Podcast — The club for people who do something about it — good news, honest numbers, one action a day.

The DP Pod: The Do Positive Podcast

The club for people who do something about it — good news, honest numbers, one action a day.

Ep 41 · Aug 20, 2026

🎧 Today's episode
Episode 41 · Moderna's personalized mRNA vaccine cut melanoma recurrence risk nearly in half in a large late-stage trial.
2026-08-20
▶ Listen now
Moderna's personalized mRNA vaccine cut melanoma recurrence risk nearly in half in a large late-stage trial.

The Positive Papers

  1. Moderna, Merck breakthrough could usher in wave of cancer vaccines
    An international team including researchers from Moderna and Merck ran a randomized late-stage trial of a personalized mRNA vaccine paired with pembrolizumab in patients with resected high-risk melanoma. The combination reduced the risk of recurrence or death by 49 percent compared with pembrolizumab alone. The vaccine works by directing the immune system to recognize up to 34 neoantigens unique to each patient's tumor. An Australian scientist led key elements of the underlying cancer vaccine research that fed into this trial. Moderna shares surged 159 percent after the late-stage results became public, with other reports noting a 150 percent rise tied to the same data. Early results suggest the approach could extend to other solid tumors, though larger trials and regulatory review are still required before broad availability. The neoantigen design tailors the mRNA sequence to mutations present only in the individual tumor, which is why the immune response stays highly specific. This development moves the tracked Global Health Progress arc forward because it shows a trial result translating into a potential deployed therapy. Manufacturing scale remains the main open question, because each batch must still be produced for one patient at a time. The open question is how quickly manufacturing scale and cost can support wider use beyond melanoma. Source: reuters.com
  2. These States Generated More Electricity From Solar Than Coal Or Natural Gas For The First Time
    Several U.S. states produced more electricity from solar than from coal or natural gas combined during recent periods, marking the first time solar has led in those grids. The shift reflects continued additions of utility-scale and distributed solar capacity plus supportive state policies. Multiple states crossed the threshold where solar output exceeded the sum of the two fossil sources in the same measured intervals. This advances the Clean-Energy Build-Out arc by showing additional regions crossing renewable-majority milestones. The remaining open question is how quickly grid-scale storage can firm the growing solar share during evening peaks. The milestone arrived without new national legislation, driven instead by falling panel costs and existing state-level incentives already in place. Source: bgr.com
  3. Rye reference genome uncovers diversity that could strengthen wheat breeding
    An international research team led by the IPK Leibniz Institute published a high-quality reference genome sequence for rye that includes the complete centromeres of all seven chromosome pairs for the first time. Centromeres are the structures responsible for correct distribution of genetic information during cell division, and their full sequences had remained incomplete in prior assemblies. The new map reveals extensive genetic diversity within rye that can now be mined for traits such as yield stability and disease resistance. Those same traits are directly transferable to wheat breeding programs because rye and wheat share large portions of their genomes. The study was published in Nature Communications and supplies breeders with a searchable catalog of gene variants that were previously inaccessible. Early applications focus on improving wheat resilience rather than creating new rye varieties, which shortens the timeline from lab to field. The open question is how many of the newly identified variants will prove stable when moved into commercial wheat lines under real growing conditions. Source: phys.org

Think Positive

Viktor Frankl observed that between any stimulus and our response lies a space where we can choose our reaction. That choice is the first freedom and the root of resilience. When news of medical or energy breakthroughs arrives, the stimulus is excitement mixed with uncertainty about timelines. Choosing one concrete next step—rather than waiting for perfect information—turns that space into forward motion. Today, name the one smallest action you can take on a health or energy choice and take it before the day ends.


The Lever

Open your last three utility bills today, average your monthly kilowatt-hour use, and enter that number plus your postcode into a free community-solar savings calculator on your utility’s site or a reputable third-party tool. The step takes roughly fifteen minutes and costs nothing. Early estimates from similar programs suggest typical bill savings in the 5–15 percent range once enrolled, though actual figures vary by location and tariff. If even one percent of listeners completed the calculation and then signed up where the numbers worked, the aggregate demand signal would be large enough to accelerate new community solar capacity in multiple regions. The common barrier is uncertainty about long-term rates; the calculator removes most of that guesswork by returning a personalized estimate in minutes. Source the impact numbers where the articles provide them: https://www.bgr.com/2236708/this-state-generated-more-electricity-from-solar-than-coal-or-natural-gas/


Do Positive Dispatch

Remember the action from yesterday—open your utility’s website or app today, enter your postcode, and check whether a community solar or green-tariff program is open for new residential sign-ups—then reply to the club email or hit the dispatch button with the single number it returned for your address.


Network pick: Fascinating Frontiers (today): "A satellite built to measure photosynthesis from orbit just received its final fuel load…"


Sources

https://www.reuters.com/legal/litigation/moderna-merck-breakthrough-could-usher-wave-cancer-vaccines-2026-08-19/ https://www.bgr.com/2236708/this-state-generated-more-electricity-from-solar-than-coal-or-natural-gas/ https://phys.org/news/2026-08-rye-genome-uncovers-diversity-wheat.html

Do something about it.

💬 Reply to this email — Patrick reads every one.

Share: X · LinkedIn · WhatsApp

Forwarded this email? Subscribe here — it's free.

▶ Listen to the podcast

📝 Read the blog  ·  🖼 Free image gallery (CC BY-SA)  ·  📊 Data Hub & Story Trackers  ·  🧭 Start Here

Nerra Network · AI-narrated voice (Grok TTS) · Editorial by Patrick

You're receiving this because you subscribed to The DP Pod: The Do Positive Podcast on nerranetwork.com.

Issue #41 · The DP Pod: The Do Positive Podcast · Aug 20, 2026
Don't miss what's next. Subscribe to Nerra Network:
← Newer Regulatory steps in South Africa and India move… · SpaceX Daily 🚀 Older → The 1986 ban was meant to end commercial whaling… · Consequences ⚖️
nerranetwork.com
Powered by Buttondown, the easiest way to start and grow your newsletter.